182 related articles for article (PubMed ID: 35581206)
1. Mutational landscape of normal epithelial cells in Lynch Syndrome patients.
Lee BCH; Robinson PS; Coorens THH; Yan HHN; Olafsson S; Lee-Six H; Sanders MA; Siu HC; Hewinson J; Yue SSK; Tsui WY; Chan ASY; Chan AKW; Ho SL; Campbell PJ; Martincorena I; Buczacki SJA; Yuen ST; Leung SY; Stratton MR
Nat Commun; 2022 May; 13(1):2710. PubMed ID: 35581206
[TBL] [Abstract][Full Text] [Related]
2. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.
Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK
Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
4. Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.
Georgeson P; Walsh MD; Clendenning M; Daneshvar S; Pope BJ; Mahmood K; Joo JE; Jayasekara H; Jenkins MA; Winship IM; Buchanan DD
Mol Genet Genomic Med; 2019 Jul; 7(7):e00781. PubMed ID: 31162827
[TBL] [Abstract][Full Text] [Related]
5. Implication of DNA repair genes in Lynch-like syndrome.
Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
Weijers DD; Hirsch S; Bakhuizen JJ; van Engelen N; Kester LA; Kranendonk MEG; Hiemcke-Jiwa LS; de Vos-Kerkhof E; Loeffen JLC; Autry RJ; Pajtler KW; Jäger N; Jongmans MCJ; Kuiper RP
Int J Cancer; 2024 Apr; 154(8):1455-1463. PubMed ID: 38175816
[TBL] [Abstract][Full Text] [Related]
8. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
9. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
10. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
[TBL] [Abstract][Full Text] [Related]
11. DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.
Pai RK; Dudley B; Karloski E; Brand RE; O'Callaghan N; Rosty C; Buchanan DD; Jenkins MA; Thibodeau SN; French AJ; Lindor NM; Pai RK
Mod Pathol; 2018 Oct; 31(10):1608-1618. PubMed ID: 29884888
[TBL] [Abstract][Full Text] [Related]
12. The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations.
Helderman NC; Bajwa-Ten Broeke SW; Morreau H; Suerink M; Terlouw D; van der Werf-' T Lam AS; van Wezel T; Nielsen M
Crit Rev Oncol Hematol; 2021 Jul; 163():103338. PubMed ID: 34044097
[TBL] [Abstract][Full Text] [Related]
13. Identification of Lynch Syndrome.
Maratt JK; Stoffel E
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):45-58. PubMed ID: 34798986
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair protein status of non-neoplastic uterine and intestinal mucosa in patients with Lynch syndrome and double somatic mismatch repair protein mutations.
Freitag CE; Chen W; Pearlman R; Hampel H; Stanich PP; Cosgrove CM; Konnick EQ; Pritchard CC; Frankel WL
Hum Pathol; 2023 Jul; 137():1-9. PubMed ID: 37030500
[TBL] [Abstract][Full Text] [Related]
16. Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
Hemminger JA; Pearlman R; Haraldsdottir S; Knight D; Jonasson JG; Pritchard CC; Hampel H; Frankel WL
Hum Pathol; 2018 Aug; 78():125-130. PubMed ID: 29723603
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.
Fu L; Sheng JQ; Li XO; Jin P; Mu H; Han M; Huang JS; Sun ZQ; Li AQ; Wu ZT; Li SR
Cell Oncol (Dordr); 2013 Jun; 36(3):225-31. PubMed ID: 23640085
[TBL] [Abstract][Full Text] [Related]
18. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
[TBL] [Abstract][Full Text] [Related]
19. Lynch syndrome: a pediatric perspective.
Huang SC; Durno CA; Erdman SH
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):144-52. PubMed ID: 24051481
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]